• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today

cafead

Administrator
Staff member
  • cafead   Jan 22, 2024 at 10:32: PM
via One pundit feels there is solid potential in one of the company's more recently approved drugs.

article source